Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study
Cancers · 10.03.2026 · 18 (6) · 894
DOI: 10.3390/cancers18060894 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancers, online erschienen am 10.03.2026. Verfasst von Min Jin Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Catholic University of Korea, Eunpyeong St. Mary's Hospital, Research Institute of Medical Science, Korea Research Foundation for Gynecologic Cancer, Catholic University of Korea, Eunpyeong St. Mary’s Hospital, Research Institute of Medical Science.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) is now widely identified as a multisystem disorder with oncogenic implications that extend beyond liver-specific outcomes. Nonetheless, the link between MASLD and gynecologic cancers remains insufficiently characterized in robust, well-powered population studies. We investigated this association by menopausal status in a large cohort of Korean women.
Methods
We performed a longitudinal cohort study utilizing data from a nationwide Korean cohort of over 2 million women, with a median observation period of 12.3 years. MASLD, including its subtypes metabolic alcohol-associated liver disease (MetALD), and alcohol-related liver disease (ALD) with metabolic dysfunction were identified using the most recent diagnostic standards. Adjusted hazard ratios (aHR) for gynecologic cancers were estimated with Cox models, accounting for metabolic, reproductive, and lifestyle factors.
Results
In premenopausal women, MASLD was associated with increased risks of cervical (aHR, 1.13, 95% CI, 1.01–1.26), endometrial (aHR, 1.63, 95% CI, 1.50–1.79) and ovarian cancer (aHR, 1.22, 95% CI, 1.12–1.33). In postmenopausal women, MASLD similarly conferred elevated risks across all three cancers: cervical (aHR, 1.12, 95% CI, 1.05–1.20), endometrial (aHR, 1.42, 95% CI, 1.32–1.54) and ovarian cancer (aHR, 1.14, 95% CI, 1.08–1.20).
Conclusions
MASLD should be considered an independent and modifiable risk determinant for gynecologic cancers. These data underscore the necessity of including hepatic steatosis in risk assessment protocols for cancer prevention. Early recognition and directed screening among metabolically susceptible women may provide important avenues for proactive cancer risk reduction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
- Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, 222 Banpo-daero, Seochogu, Seoul 06591, Republic of Korea.
- Department of Statistics and Actuarial Science, Soongsil University, Seoul 06978, Republic of Korea.
ORCID-Profile: Min Jin Jeong, Yong Seok Lee, Youn Jin Choi
Förderung
- the Catholic University of Korea, Eunpyeong St. Mary's Hospital, Research Institute of Medical Science
- Korea Research Foundation for Gynecologic Cancer
- Catholic University of Korea, Eunpyeong St. Mary’s Hospital, Research Institute of Medical Science
Zitieren
APA
Jeong, M. J., Lee, Y. S., Choi, Y. J., & Han, K. D. (2026). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study. Cancers, 18(6), 894. https://doi.org/10.3390/cancers18060894
Vancouver
Jeong MJ, Lee YS, Choi YJ, Han KD. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study. Cancers. 2026;18(6):894. doi:10.3390/cancers18060894
BibTeX
@article{Jeong2026,
author = {Jeong, Min Jin and Lee, Yong Seok and Choi, Youn Jin and Han, Kyung Do},
title = {Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Gynecologic Cancer: A Nationwide Cohort Study},
journal = {Cancers},
year = {2026},
volume = {18},
number = {6},
pages = {894},
doi = {10.3390/cancers18060894}
}
EUVIMED